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SUMMARY 
Multidrug resistance (MDR) is a major obstacle in cancer therapy. It results from different mechanisms; among them 
is P-glycoprotein (P-gp)-mediated drug efflux out of cells. The mechanism ofaction remains elusive. The membrane lipid 
surrounding of P-gp, especially cholesterol, has been postulated to play an important role. To determine the effect of 
cholesterol depletion on P-gp, Madin Darby canine kidney (MDCK) cells, transfected with the mdrl gene (MDR1-MDCK 
cells), were treated with methyl-~-cyclodextrin (MI3CD). The localization and function of P-gp were analyzed using 
confocal aser scanning microscopy. Treatment with 100 mM M~CD did not affect viability but altered the structural 
appearance of the cells and abolished efflux of rhodamine 123, a P-gp substrate. The M~3CD treatment released P-gp 
from intact cells into the supernatant and reduced the amount of P-gp in total membrane preparations. The P-gp was 
shifted from the raft fractions (1% Triton X-100, 4 ~ C) to higher density fractions in MI3CD-treated cells. The amount of 
cholesterol was significantly decreased in the raft fractions. Treatment of cells with 1-phenyl-2-decanoylamino-3-mor- 
pholino-l-propanol, a glucosylceramide synthase inhibitor, also led to a shift of P-gp to higher density fractions. These 
results how that removal of cholesterol modulates the membrane lipid composition, changes the localization of P-gp, and 
results in loss of P-gp function. 
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INTRODUCTION 
The expression of multidrug resistance proteins at the blood- 
brain barrier (BBB), in tumor tissue, and in T cells prevents many 
pharmacologically potent central nervous ystem, antitumor, or anti- 
human immunodeficiency virus drugs from reaching their target. 
The human muhidrug resistance (MDR1), P-glycoprotein (P-gp), be- 
longs to the adenosine triphosphate (ATP)-binding cassette super- 
family of membrane transporters. The P-gp transports compounds 
in an unmodified state and is therefore of particular interest for 
drug uptake, distribution, and elimination. It has primarily been 
described as a drug efflux pump, which mediates muhidrug resis- 
tance. The extent to which P-gp and other multidrug resistance 
proteins directly pump compounds across the plasma membrane of
cells or transloeate hem between the two membrane l aflets is not 
clear, nor is to what extent heir drug transport capability is based 
on lipid sorting, thus influencing the physieochemical characteris- 
tics of the plasma membrane (Sharom, 1997; Roepe, 1998; Eytan 
and Kuchel, i999). There is strong evidence that the lipid com- 
position of biological membranes and the flmetion of proteins uch 
as P-gp are closely related (Modok et al., 2004; Norris-Cervetto et
al., 2004; Troost et al., 2004). 
In Madin Darby canine kidney (MDCK) cells, stably transfeeted 
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with the mdrl gene (MDR1-MDCK cells), P-gp is highly expressed 
and homogenously distributed on the cell layer already a few days 
after seeding. This is in contrast to Caco-2 cell cultures that express 
P-gp after 2-3 wk in lower amounts and limited to patches of the 
cell layer (Braun et al., 2000; Hammerle t al., 2000; Tang et al., 
2002). The P-gp is primarily localized in the apical plasma mem- 
brane (Simons and Ikonen, 1997; Hammerle t al., 2000; Luker et 
al., 2000), which is enriched in cholesterol, glycosphingolipids 
(GSLs), and sphingomyelin (SM) (Simons and van Meer, 1988; 
Hooper, 1999). The MDR1-MDCK cells thus represent an ideal 
system to study the influence of the modulation of lipids on the 
localization and function of the P-gp. 
The P-gp is predonfinantly localized in low-density caveolae-en- 
riehed domains (rafts) (Lavie et al., 1998; Demeule et al., 2000; 
Luker et al., 2000). To better understand the role of the lipid en- 
vironment on proteins, different methods have been developed to 
isolate specific membrane domains (Hooper, 1999; Pike, 2003a, 
2003b). Detergent-resistant raf s, prepared in cold buffer containing 
1% Triton X-IO0 (Brown and Rose, 1992), are enriched in choles- 
terol and GSLs (Pike, 2003a); hence, their role on the localization 
and function of P-gp is of interest. 
To determine the effect of modulation of cholesterol and GSLs in 
MDR1-MDCK cells, cholesterol was depleted with methyl-~-cyclo- 
dextrin (Mf3CD) (Ilangumaran d Hoessli, 1998), and the synthesis 
of GSLs was inhibited with 1-phenyl-2-decanoylamino-3-morphol- 
ino-l-propanolol (PDMP) (Lavie et al., 1997, 1999; Lucci et al., 
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1999; Sietsma et al., 2000; Plo et al., 2002). The localization of P- 
gp and the efftux of rhodamine 123 (rho123), a P-gp substrate, in 
Ml3CD-treated cells were studied using confocal aser scanning mi- 
croscopy (CLSM). The release of P-gp from viable cells and from 
total membrane preparations after M[~CD treatment was detected by 
immunoblotting. Lipid rafts were prepared in cold buffer containing 
1% Triton X-100, from M[3CD- or PDMP-treated cells and untreated 
cells, and P-gp and lipid distributions in rafts and nonraft fi'actions 
were analyzed by immunoblotting and thin layer chromatography 
(TLC), respectively. 
MATERIALS AND METHODS 
Cell culture and treatment with MI3CD and PDMP. The MDCK cells trans- 
fi~cted with the mdrl gene (MDR1-MDCK) were a gift fi'om Ira Pastan. They 
were propagated in Dulbecco modified Eagle medium with Glutamax-I (In- 
vitrogen AG, Basel, Switzerland), as described previously (Pastan et al., 1988; 
Hammerle t al., 2000). The CLSM studies were performed on cell cultures 
grown on cell culture inserts, whereas the other experiments were performed 
on cell cultures grmvn in plastic culture flasks (Hannnerle t al., 2000). In 
all experiments, the passage number was below 50 and unless otherwise 
stated, cell cultures were used 11 d after seeding, which corresponded to the 
stationary growth phase (Braun et al., 2000; Hammerle t al., 2000). In the 
subsequent experiments, all solutions contained protease inhibitors, and the 
experiments were performed at least three times. 
Stock solutions of 200 and 500 nv~/ M[3CD (Waeker Chemic AG, Burg- 
hausen, Gem~any) were prepared in distilled watel: Cells were incubated for 
1 h in serum-free medium befin'e they were treated with 20, 30, or 
100 mM MI3CD for 30 nfin, 1 h, and 2 h, respectively, at37 ~ C. Untreated 
control cells were prepared sinfilarly to the Ml3CD-treated cells. The super- 
natants above the control and MI3CD-treated cells in the culture flasks were 
collected for further processing. The culture flasks were rinsed thrice with 
Earle's balam'~ed salt solution (EBSS) (]nvitrogen) before the cells were har- 
vested by scraping and subsequently washed thrice with phosphate-buffered 
saline (PBS; 10 mM Na2HPOt-KH2PO~, 130 ntM NaCI, pH 7.4) before being 
processed, as indicated below. 
To determine the effect of PDMR cell cultures were grmvn for 9 d before 
30 IxM PDMP (Sigm~Aldrich, Buchs, Switzerland) was added in fresh me- 
dium (di Bartolomeo and Spinedi, 2001). The cells were incubated for 48 h 
at 37 ~ C, rinsed thrice with EBSS, and harvested by scraping before being 
used tor raft preparation as described below. 
Imm~nqfluorescent labeling. The cells were p~pared for CLSM, as de- 
scribed previously (Pastan et al., 1988; Rothen-Rutishauser et al., 1998; 
Hammerle t al., 2000). The following antibodies, diluted in PBS containing 
3% (w/v) bovine serum albumin and 0.1% (w/v) saponin, were used for la- 
beling: mouse monoclonal 4E3 anti-P-gp (Dako Diagnostics AG, Copenha- 
gen, Denmark) 1:10, mouse monoclonal antioccludin (Zymed Laboratories 
Inc., San Francisco, CA) 1:100, and rabbit anticaveolin (BD Transduction 
Laboratories, San Jose. CA) 1:100. Anti-rabbit cyanine 3 and anti-mouse 
cyanine 3 (Sigma) 1:50, were used as seconda~, antibodies. F-actin was 
stained with Alexa Fluor 660 phalloidin 1:50 and nuclei with 1 Ixg/ml 4',6- 
diamidino-2-phenylindole (DAPI) (Molecular Probes, Leiden, The Nether- 
lands). Preparations were studied with a Zeiss LSM 410 inverted microscope, 
and for image reconstruction, the IMARIS software (Bitplane, Zurich, Swit- 
zerland) was used (Hainmerle t al., 2000). 
The rho123 efflux assa): The efflux assay was performed, as described 
previously (Fontaine et al., 1996; Hammerle t al., 2000). The efflux of 
rho123 (Sigma) was observed in the CLSM by z-scans of the cell layers and 
of the adjacent apical extracellular space. For a better orientation, the nuclei 
were stained using Hoechst 33342 (Molecular Probes). For P-gp inhibition 
studies, 0.1 mM verapamiI hydrochloride (Sigma) was added 5 rain before 
the addition of rho123 and Hoechst 33342 and to all solutions throughout 
the assay. 
Viability tests. The viability of Ml~CD-treated and untreated cells was de- 
terulined using the Live/Dead viability/cytotoxicity Kit that contained the two 
fluorescent probes, calcein AM and ethidium homodimer-1 (Molecular 
Probes). Calcein AM is cleaved by cytosolic esterases toits green fluorescent 
metabolite calcein in live cells, whereas ethidimu homodimer-1 permeates 
dead cells and stains their nuclei red (Neethling et al., 1999; Wagner et al,, 
1999). TO some of the control (;ells, 0.1 nff/ verapamil was added before 
staining with Live/Dead Kit to inhibit the P-gp efflux function because calcein 
AM is a P-gp substrate (Loor et al., 2002; Kohler and Stein, 200.3). An 
additional control, of nonviable MDR1-MDCK cells, rinsed thrice with hot 
EBSS, was also included in the assay. The viability of Ml3CD-treated cells 
was additionally tested in 96-well plates using the (3-(4,5-dimethyhhiazol-2- 
yl)-2,5-diphenyl tetrazolium bromide (MTT) assay (Mosmann, 1983; van de 
Loosdrecht et al., 1994). 
Preparation of total membranes and treatment with M~CD. Total membrane 
fractions were prepared, as described previously (Ilangumaran and Hoessli, 
1998). In brief, 2.5 X 10 a cells were resuspended in 5 ml of hypotonic buffer 
(10 n~/ Tris-HC1, 10 mM KC1, 5 mM MgClz, 1 n~l// ethylene glycol- 
bis(aminoethylether)-tetraacetic acid, pH 7.4) and homogenized using a 
Dounce homogenizer (50 strokes, 1000/rain). After centrifngation at2000 X 
g for 10 rain at 4 ~ C, the supernatant was layered over 5 ml of 40% (w/v) 
sucrose in Tris-NaCI-EDTA buffer (TNE) buffer (25 mM Tris-HCl, 150 mM 
NaCI, 5 mM ethylenediaminetetraacetic acid [EDTA], pH 7.4) and centri- 
fuged at 100,000 • g for 1 h at 4 ~ C. The light scattering band containing 
the total membranes, above the sucrose cushion was collected and divided 
into four fractions, which were treated with MI3CD, as stated above, with 
intermittent shaking. Subsequently, the sample volumes were adjusted to 5 
ml with the TNE buffer and layered over 5 ml of 40% (w/v) sucrose, and the 
procedure was repeated as described above. After centrifugation, the volume 
of the resulting membrane fractions were adjusted to 3 ml with TNE buffer, 
and samples centrifuged at 250,000 • g for 3.5 h at 4 ~ C- The pellets were 
collected and dissolved in 100 I*1 sample buffer (Laemmli, 1970). 
Differential centrifugation of cell supernatant. The supernatants from 2.5 
x 10 a Ml3CD-treated and untreated cells were collected and centrifuged at 
2000 x g for 10 min at 4 ~ C. The cell-free supernatants were further cen- 
trifuged at 10,000 • g for 15 rain at 4 ~ C in a $4180 rotor (Beckman 
Instruments). The pellets were collected and dissolved in 100 tL1 sample 
buffer for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS- 
PAGE) and immunoblotting or in 300 Ixl chloroform-methanol (2:1, v/v), for 
lipid analysis. 
Preparation of rafts. Rafts were prepared as described previously (Brown 
and Rose, 1992); in brief, 2.5 x 10 ~ MI3CD-treated and untreated cells were 
lysed for 20 rain on ice in 2 ml TNE buffer containing 1% (v/v) Triton X- 
100 (Laemmli, 1970; Brown and Rose, 1992). After homogenization, the ho- 
mogenate was mixed with an equal volume of 80% (w/v) sucrose solution in 
TNE buffer and overlaid with a discontinuous sucrose gradient (2 ml each 
of 30, 20, 10%, and 1.5 ml of 5% [w/v] sucrose, all in TNE buffer without 
Triton X-IO0). After eentrifugation at 200,000 X g for 19 h at 4 ~ C, in a 
SW41Ti rotor (Beckman Instruments, Fullerton, CA), 1 lnl fractions were 
collected ti'om the top of the gradient (fractions 1-12) without including the 
pellet at the bottom. Raft ii"aetions 4-7 had higher optical densities (620 nm) 
than the rest of the fractions (Hooper, 1999) and densities of 1.06-1.13 
cm :~, calculated from their respective refractive indices (refractometel; Bel- 
lingham and Stanley Inc., Tunbridge Wells, U.K.). The size intensity distri- 
bution and polydispersity factor, deternfined with a Zetasizer 3 (Malvern In- 
struments, Worcestershire, UK), gave the "average mean diameter" of 265.8 
-+ 5.8 nm, with a mean polydispersity factor of 0.45 -+ 0.03. The distribution 
of protein along the gradient was characteristically skewed, with most protein 
being concentrated within fractions 7-12 (density range 1.13-I.20 g/enP). 
Each fraction was sedimented similarly to the membrane fractions and the 
pellets dissolved in 100/xl sample buffer for SDS-PAGE and immunoblotting. 
The SDS-PAGE and immunoblots. Dissolved samples were analyzed im- 
mediately or stored at -70  ~ C. The protein concentrations were determined 
with the Bio-Rad D c protein assay (Bradford, 1976). Samples were denatured 
by heating for 5 rain at 95 ~ C, before being loaded onto a 7.5% (w/v) gel for 
P-gp detection (4/xg protein/slot) or onto a 15% (w/v) gel for eaveolin de- 
tection (2 Ixg protein/slot). After SDS-PAGE and Western blotting (Hammerle 
et al., 2000), the antibody labeling was peKonned with the monoelonal mouse 
anti-human P-gp antibody C219 (Dako) or rabbit antiactin (Sigma) (1:500) or 
with rabbit anticaveolin antibody (1:5000). The nitrocellulose membranes 
were subsequently incubated with the anti-mouse (1:30,000) and anti-rabbit 
(1:50,000) secondary antibodies conjugated with alkaline phosphatase (Pierce 
Biotechnology, Rockford, IL). They were analyzed with an enhanced chemi- 
luminescence immunoblotting detection system (BioRad Laboratories Inc., 
Hercules, CA). 
Lipid analysis. For lipid analysis, 4.1 X 107 cells were washed and har- 
vested by scraping, and lipids were extracted from the cell pellet using 1 ml 
of chloroform-methanol (2:1, v/v). Lipids were identified and quantified, as 
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described previously (Brown and Rose, 1992; Kramer et zl., 2002). In brief, 
25 ~1 of the lipid extracts were applied onto TLC silicagel 60 aluminmn 
sheets (Merck, Darmstadt, Germany) together with a series of different vol- 
umes (1-25 ~1) of the reference stock solution (Shand and Noble, 1980; 
Kramer et al., 2002). Polar lipids were developed with chloroform-methanol- 
acetic acid-water (60:50:1:4, v/v), neutral ipids in heptane-diethylether- 
acetic acid (60:40:2, v/v), and GSLs in chloroform-methanol-water (65:25:4, 
v/v). The dried TLC sheets were sprayed with an aqueous olution of 3% 
(w/v) cupric acetate and 8% (v/v) phosphoric acid (Shand and Noble, 1980). 
The dried sheets were heated for 15 rain at 180 ~ C to char the lipids. The 
TLC plates were scanned and subsequently analyzed by the computer pro- 
gram Scion Image (Scion Corp., Frederick, MD) using the macro gelplot2. 
The dark spots were thus converted to density peaks, which were quantified 
by the area under the curve (AUC). The correlation between the AUCs and 
the lipid concentrations of the reference spots was determined and used to 
calculate the concentrations of the extracted lipids (Kramer et al., 2002). 
Lipid analysis of the raft and nonraft fractions was performed on fr~ctions 
separated on a discontinuous sodium bromide (NaBr) gradient instead of a 
sucrose gradient. The homogenate was mixed with an equal volume of 64% 
(w/v) sodium bromide stock solution in PBS. The sample was overlaid with 
2 ml of 1.73 M NaBs, 2 ml of 0.87 M NaBr (both in 0.2 M NaC1 and 
0.34 nrM EDTA, pH 7.78), and 2 mI PBS. Alter centrifugation, 1-ml fractions 
were transferred into cellulose membrane dialysis tubes (Sigma) and dialyzed 
against distilled water for 8 h at room temperature. The fractions wm~ then 
lyophilized overnight at -20 ~ C in 20-ml, thick-walled glass bottles. The 
residue was transferred into 1.5-ml Eppendorf tubes containing 1ml of" chlo- 
roform-methanol (2:1, v/v), and the tubes were placed on a shaker overnight 
at 4 ~ C. The superuatant containing the lipids was collected alter 5 rain 
centrifugation i  a microfuge, and the lipids were analyzed, as indicated 
above. 
The amount of cellular, nonesterified cholesterol in ] 00 mM Ml3CD-tweated 
and untreated cells was additionally determined using the Amplex | Red 
Cholesterol Assay Kit (Zhou et al., 1997). 
RESULTS 
Localization of P-gp, caveolin, and occludin in Ml~CD-treated 
cells. The CLSM showed no significant difi~rence between control 
cells (Fig. 1A-C) and cells treated with 30 mM of M[3CD for 1 h 
(Fig. 1D-F). In both cases, most of the P-gp was located in the 
apical plasma membrane of the topmost layer of cells. However, 
treatment with 100 nrM M[3CD for 2 h resulted in an apparent 
decrease of P-gp at the apical plasma membrane. The appearance 
of the immunolabeling was changed to a punctuate pattern, and the 
cells started to round up (Fig. 1G and H). 
The localization and distribution of the raft protein caveolin and 
the tight-junction protein occludin were also studied using CLSM. 
There was no significant dill)fence between the distribution of car- 
colin in control (Fig. 2A-C) and in 100 mM M[3CD-treated cells 
(Fig. 2D-F). In cells treated with 100 mM M[3CD (Fig. 2J-L), oc- 
cludin was still found at the cell borders; howevel, the tight junc- 
tions appeared loosened and swollen when compared with the con- 
trol cells (Fig. 2G-/). Some intracellular labeling of occludin was 
also observed. 
The P-gp efflux function and viability of M~CD-treated cells. Con- 
focal microscopy showed that rho123 was effluxed to the extracel- 
lular space in control cells and in cells treated with 20 mM M[3CD 
for 30 rain (Fig. 3A and C). 3)'eatment with 30 mM MI3CD fur 1 h 
also resulted in efflux; however, some of the rho123 was retained 
within the cells (Fig. 3E). The efflux was completely inhibited by 
treatment with 100 mM M[3CD for 2 h (Fig. 3G). A similar effect 
was observed in cells treated with verapamil, a known inhibitor of 
P-gp efflux activity, independent of the M[3CD treatment (Fig. 3B, 
D, F, and H). 
To exclude the possibility that the loss of efflux activity after 
treatment with 100 mM MI3CD, which could be because of a loss 
of cell viability, the calcein AM-ethidium homodimer viability assay 
was performed. Cells remained viable after treatment with 30 and 
100 nrM M[3CD for 1 and 2 h, respectively, as indicated by the 
green staining of cells and the lack of red nuclei (Fig. 4D and E). 
In contrast, in nonviable cells, no calcein was detected, and ethi- 
dium homodimer permeated the cells resulting in red staining of 
the nuclei (Fig. 4C). The green calcein staining of control cells was 
stronger after verapamil incubation because the efflux of calcein 
AM by P-gp was inhibited (Fig. 4A and B) (Kohler and Stein, 2003). 
The MTT assay results showed that none of the MI3CD concentra- 
tions used in our study did affect the viability of the cells. The 
metabolic activity of cells treated with 100 nr/V/ M[3CD remained 
109 -+ 22% of the control ceils. 
Effects of M~CD treatment on P-gp and caveolin in total mem- 
branes and in supernatants. Treatment of membrane fractions with 
100 mM MI3CD for 2 h resulted in a significant decrease in the 
amount of P-gp (Fig. 5A). In contrast, the amount of caveolin in the 
total membranes was not affected by M[3CD treatment. 
Analysis of the supernatants of control and cells treated with 
20 mM M[3CD for 30 min showed that only traces of P-gp were 
detected in the 10,000 • g pellets. In contrast, a substantial 
amount of P-gp was released after treatment of cells with 50 mM 
M[3CD for 30 min and to an even higher extent after treatment with 
100 nrM M[3CD for 2 h (Fig. 5B). Caveolin and actin were present 
in all supernatants independent of M[3CD treatment (Fig. 5B and 
data not shown). 
Distribution of P-gp and caveolin in raft and nonrafi fractions 
prepared from cells treated with either M~CD or PDMP. In control 
cells, there was an enrichment of P-gp in the raft fractions at a 
density range of 1.06-1.13 g/cm ~ (Fig. 6A). A tendency for the 
distribution of P-gp over a slightly wider density range (1.06-1.15 
g/cm z) was detected in cells treated with 20 mM of M[3CD for 
30 rain, and treatment of cells with 100 n~/M[3CD for 2 h resulted 
in a significant shift of P-gp from the raft fractions to higher density 
ti'actions (1.18-1.20 g/cm:~). Only a small amount of P-gp remained 
in the raft fractions of cells treated with 100 mM M[3CD. A similar 
shift was also observed after treatment of ceils with PDMP for 
48 h. The distribution of caveolin was not significantly affected by 
these treatments (Fig. 6B). 
Lipid composition of cell lysates and raft and nonrafi fractions of 
cells treated with either M~CD or PDMP. Glycerophospholipids 
(phosphatidylsevine, PS; phosphatidylethanolanline, PE; phospha- 
tidylcholine; and phosphatidylinositol) represented 55% (mol/mol) 
of total analyzed lipids in cell lysates of control cells. Cholesterol 
was the most abundant lipid accounting for 30%, whereas GSLs 
represented 9% of the total lipids (Fig. 7A). Treatment of cells with 
100 nrM M[3CD reduced the amount of cholesterol in the cell lysates 
to 21.4 + 4.7 nmol, which was 13.5% (mol/mol) of total analyzed 
lipids (Table 1), and corresponded to45% of the cholesterol content 
of control cells (47.5 +- 5.4 nmol) (Fig. 7A; Table 1). Results fi'om 
the Amplex | Red assay showed that Ml3CD-treated cells contained 
about 36% cholesterol of control cells. 
In ratis, glycerophospholipids accounted for 49%, with PE repre- 
senting 21% of the total analyzed rafts lipids. Cholesterol was the 
most abundant raft lipid representing 37% of analyzed raft lipids, 
whereas SM and GSLs accounted for 7% each (Fig. 7B and D). Anal- 
ysis of the distribution of individual ipids in the gradients howed 
that 70% of GSLs, 56% of SM, and 47% of cholesterol were in the 
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FIG. I. Effect of methyl-13-cyclodextrin (M[3CD) on the localization and distribution of P-glycoprotein (P-gp) in MDR1-MDCK cells. 
Cells were stained for P-gp (red), actin (g~en), and nuclei (blue) and studied by confocal laser scanning microscopy. A-Hare xy-projections, 
('), xz-projections, and ("), yz-projections. Arrows indicate the section levels. In B, E, and H, only P-gp and nuclei are shown for clarity, 
whereas C, F, and 1 are shadow projections. Most of P-gp was located in the apical membrane of both the control cells (A-C) and the 
cells treated with 30 mM MI3CD (D-F). Treatment of cells with 100 mM MI3CD resulted in an apparent dem~ase of P-gp (G o at the 
apical membrane and the residue labeling was punctuated. Figure is published in color online at http://inva'allenpress'c~176 
?request=index.htmh 
raft fractions (Fig. 7B and C). There was a significant decrease in the 
amount of cholesterol ira the raft fractions of cells treated with 100 
mM MI3CD (Fig. 7B), and the residual cholesterol was 4.1 -+ 1.6 
nmol, which corresponded to 15% (tool/tool) of the cholesterol in raft 
fractions of control cells (27.6 + 5.6 nmol). Instead of cholesterol, 
PE was the most abundant raft lipid constituting 24% of the raft 
lipids (Table 1). Cholesterol was also significantly decreased in the 
nonraft fractions after M[3CD treatment (Fig. 7C). 
The amount of GSLs in the cell lysates of PDMP-treated cells 
decreased significantly from 14.6 -+ 2.8 in the control cells to 4.1 
-4- 1.6 nmol (Fig. 7A). The molar percentages of GSLs in the rafts 
and in nonraft fractions were in the same range as for the control 
cells (Fig. 7B and C). 
The supematant of control ceils contained 2.7 + 0.3 nmol cho- 
lesterol/rag protein and 0.2 _+ 0.1 nmol GSLs/mg protein. The l ip id-  
protein ratio increased significantly in the supematant of ceils treat- 
ed with 100 nff/M[3CD to 7.2 + 2.2 nmol/mg protein and 3.7 -+ 
2.7 nmol/mg protein, respectively. 
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FIG. 2. Distribution of caveolin and occludin in MDR1-MDCK cells after nlethyl-13-cyclodextrin (MI~CD) treatment. Immunolabeling 
of caveolin (A-F, red), occlndin (t-L, red), actin (green), and nuclei (blue). Sections and shadow projections are as indicated in Fig. 1. 
There was no significant diflhrence in the distribution of caveolin between control (A-C) and in cells treated with 100 raM MI3CD (D E). 
Occludin was still found in the cell [)orders of 100 nrM Ml3CD-treated cells (G-/); however, tight junctions appeared loosened, and some 
intracellular staining was detected. Figure is published in color online at http://inva.allenpress.com/invaonline/?request=index.htmh 
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FIG. 3. Inhibition of efflux of rhodamine123 (rho123) ti'om methyl-13-cyclodextrin (MI3CD)-treated MDR1-MDCK cells. The efflux of 
rho123 from control and MI3CD-treated cells was observed by eonfoeal laser scanning microscopy. Rho123 (red) was effluxed to the 
extracellular space of control (A) and of 20 mM MI3CD-treated cells (C). Some rho123 was retained in c lls treated with 30 mM MI3CD 
(E). Treatment with 100 mM MI3CD resuhed in a complete inhibition of rho123 efflux (G) to a similar extent as in cells treated with 
verapamil (B, D, F, and H). Nuclei (blue) are stained with Hoechst 33342. Figure is published in color online st http://inva.allenpress.com/ 
invaonline/?request = index.html. 
FIG. 4. Viability of methyl-13-eyclodextrin (MI3CD)-treated MDR1-MDCK cells. The viability of contro  and MI3CD-treated cells was 
tested with calcein AM and ethidium homodimer (Live/Dead Kit reagents). Treatment of cells with verapamil (B) inhibited the efflux of 
calcein AM and hence smmger green calcein staining than in the untreated control cells (A). No calcein was detected in nonviable cells 
(C), and ethidium homodimer permeated the cells resulting in red staining of the nuclei. Cells t~ated with 30 and 100 n~/MI3CD (D 
and E) were viable, and catcein AM was cleaved to green calcein. Nuclei (blue) are stained with Hoechst 33342. Figure is published in 
color online at h tp://inva.allenpress.com/invaonline/?~quest-index.html. 
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FIG. 5. Release of P-glycoprotein (P-gp) from cellular membranes of 
MDR1-MDCK cells. The P-gp and caveolin contents in total membranes 
treated with methyl-[3-cyclodextrin (MI3CD) (A) and in cell-free supernatants 
of cells treated with M[3CD (B) were analyzed by immunoblotting. Treatment 
of total membrane with 100 mM MI3CD resuhed in a significant decrease of 
P-gp (A). A substantial amount of P-gp was released into the cell-free su- 
pernatant of cells treated with increased concentrations of MI3CD, especially 
after treatment with 100 mM M[3CD (B). The amount of caveolin in total 
membranes and in the supematant remained unchanged despite the M[3CD 
treatments (A and B). 
FIG. 6. Shift of P-glycoprotein (P-gp) from raft o nonraft fractions after 
methyl-I3-cyclodextrin (MI3CD) and 1-phenyl-2-decanoylamino-3-morpholi- 
no-l-propanolol (PDMP) treatment ofMDR1-MDCK cells. The P-gp and cav- 
eolin contents in rafts (4-7) and nonrafts (8-12) ti'actions of cells treated 
with M[3CD or PDMP were analyzed by immunoblotting. Treatnmnt of cells 
with 100 mM M[3CD and 30 ~ PDMP ~sulted in most of P-gp being shifted 
fi"om the raft fractions to higher density fi'actions. The shit} was only slight 
in cells treated with 20 mM MI3CD for 30 min. Caveolin was not affected 
significantly by these treatments. 
FIG. 7. Reduction of cholesterol and GSLs in methyl-I3-cyclodextrin 
(M[3CD) and 1-phenyl-2-decanoylamino-3-mo~pholino-l-propanolol (PDMP)- 
treated MDR1-MDCK cells. Lipid composition of control cells (black bars) 
and cells treated with 100 mM M[3CD (unshaded bars) or 30 ~M PDMP 
(dotted bars) were analyzed in the cell lysate (A), rait (B), and nonrat} fractions 
(C), and the distribution of cholesterol (nmol/mg protein) in the sodimn bro- 
mide gradient of control ( ' )  and 100 mM Ml3CD-treated cells (U]) were 
determined (D). Treatment of cells with MI3CD resulted in a significant de- 
ci~ase of cholesterol, especially in the raft fractions. The amount of GSLs 
were decreased significantly in the cell lysates after treatment of cells with 
30 ~M PDMP. Data represent the mean values -+ S.D. of at least three 
independent experiments. Statistical significance compared with untreated 
cells is shown as (*) with P < 0.05. Abbreviations: SM, sphingomyelin; PC, 
phosphatidylcholine; PS, phosphatidylserine; PI, phosphatidylinositoI; PE, 
phosphatidylethanolamine; Chol,cholesterol; GSL, glycosphingolipids. 
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TABLE 1 
LIPID AND PROTEIN AMOUNTS IN CELL LYSATES, RAFT, AND 
NONRAFT FRACTIONS a 
Total ipids (nmol) Total protein (rag) 
Control 
Cell lysate 168.5 • 12.2 72.3 -+ 2.3 
Rafts 75.0 -- 9.3 1.2 _+ 0.5 
Nonrafts 121.5 +- 8.9 18.1 • 3.6 
100 mM M[3CD 
Cell lysate 161.7 • 20.0 62.9 • 4.5 
Rafts 34.7 • 8.5 1.1 • 0.6 
Nonraf~cs 90.6 • 7.5 11.1 • 3.2 
30 IxM PDMP 
Cell lysate 173.2 • 13.7 73.3 • 2.3 
Rafts 100.2 • 7.3 2.4 • 0.8 
Nonrafts 97.3 -+ 9.1 20.3 • 1.5 
~ Lipid and protein amounts in cell lysates, raft, and nonrafl fractions of 
methyl-13-cyctodextrin (M[3CD)- and PDMP-treated ceils were analyzed, and 
data represent the mean amounts • S.D. of ~3 independent experiments. 
Treatment of cells with 100 mM MI3CD resulted in decrease in amount of 
lipids especially in the raft fractions where the decrease was significant. 
DISCUSSION 
The MDR1-MDCK cells expressing high amounts of P-gp on the 
apical plasma membrane represented an ideal system to elucidate 
the mechanisms of action of the protein after modulation of mem- 
brane lipid composition. Treatment of MDR1-MDCK cells with 
100 mM MI3CD reduced the amount of cholesterol in the total cell 
lysate, and the reduction was most significant in the raft fractions. 
This was accompanied by an apparent thinning out of the P-gp at 
the apical cell surface. Under these circumstances, efflux of rho123 
was abolished, although the M[3CD-treated cells remained viable. 
A recent study showed that P-gp interferes with the MTT assay 
(Vellonen et al., 2004); however, the cleavage of calcein AM and 
the exclusion of ethidium homodimer f om the nuclei of cells treated 
with M[~CD confirmed their viability. Our study indicates that the 
residual P-gp in M[~CD-treated cells was not effective for the efflux 
of rho123. This was consistent with previous tudies, which showed 
that depletion of cholesterol impaired P-gp-mediated drug transport 
in different cell lines (Luker et al., 2000; Yunomae et al., 2003; 
Arima et al., 2004). Our lipid and immunoblot analyses of the su- 
pernatant of MlSCD-treated cells showed that cholesterol depletion 
was accompanied by release of large amounts of P-gp together with 
significant amounts of GSLs from the cell surface. The release or 
shedding of membrane components, which includes transmembrane 
proteins uch as P-gp, CD30 glycoprotein, and interleukin-6 recep- 
tor, after cholesterol depletion, is a phenomenon that was also re- 
ported in previous studies (Xie and Low, 1995; Ilangumaran and 
Hoessli, 1998; Matthews et al., 2003; Yunomae et al., 2003; Arima 
et al., 2004; yon Tresckow et al., 2004). In contrast to P-gp, caveolin 
was present in all the supernatants independent of MI3CD treat- 
ment. When total membranes were treated with M[3CD, P-gp was 
also released, whereas caveolin was not. 
The raft-associated proteins, influenza virus hemagglutinin and 
placental alkaline phosphatase, were reported to shift from the raft 
to the nonraft fractions after MI3CD treatment of ceils (Scheiffele t 
ah, 1997; Ilangumaran and Hoessli, 1998). In these studies, the 
effect was tentatively related to the disorganization and loss of in- 
tegrity of rafts brought about in the membrane by the removal of 
cholesterol. 
Our study showed that the removal of cholesterol with M[3CD 
resulted in modulation of the lipid composition of the rafts. Cho- 
lesterol was no longer the most abundant lipid. This was accom- 
panied by a shift of P-gp from the raft to the nonraft fractions. 
Caveolin localization in the rafts remained unchanged, consistent 
with results from previous tudies (Seheiffele t al., 1997; Luker et 
al., 2000; Yunomae et al., 2003; Arima et al., 2004). This indicated 
a clear difference in the susceptibility of P-gp and eaveolin to de- 
pletion of cholesterol. A heterogeneity in the lipid raft components 
in terms of their dependence on or interaction with cholesterol has 
been shown (Pike, 2003b). It can, thus, be hypothesized that the 
difference in susceptibility between P-gp and eaveolin results from 
low M[~CD accessibility of cholesterol within eaveolae and a rela- 
tively high affinity between eaveolin and cholesterol (Foster et al., 
2003; Magee and Parmryd, 2003). 
Investigations in our laboratory have shown that P-gp in rafts 
prepared from MDR1-MDCK cells have a distinct, substrate con- 
centration-dependent ATPase activity (Bucher et al., 2005). No ac- 
tivity was found in rafts prepared from M[3CD-treated cells. It re- 
mains to be demonstrated whether this loss of activity is because 
of the reduced amount of P-gp or cholesterol (or both) in the raft 
fractions, since the basal ATPase activity of P-gp reconstituted in
proteoliposomes has been shown to increase on incorporation of 
cholesterol into the membrane (Rothnie et al., 2001; Modok et al., 
2004). Further studies will confirm whether the loss of P-gp efflux 
activity after depletion of cholesterol is also because of the change 
of the lipid composition in the vicinity of P-gp. 
There was a decrease of GSLs in the total cell lysate of MDR1- 
MDCK cells treated with PDMP, which was consistent with results 
from previous studies with 3LL carcinoma nd Jurkat cells (Ino- 
kuchi et al., 2000; Nagafuku et at., 2003). Our study shows for the 
first time that in PDMP-treated cells, P-gp was shifted to the nonraft 
fractions. Similar results have been reported for the Src kinase, 
which is raft associated in control 3LL carcinoma ceils but shifted 
to the nonraft fractions after treatment with PDMP (Inokuchi et al., 
2000). Plo et al. (2002) showed that PDMP treatment also inhibits 
the efflux of rho123 by P-gp. In a recent study, Non'is-Cervetto et
al. (2004) came to the conclusion that chemosensitization of cells 
expressing P-gp could not be attributed to the inhibition of gluco- 
sylceramide synthase alone. The shift of P-gp from the raft fractions 
shown in our study could be an explanation for the loss of efflux 
activity of P-gp after PDMP treatment. Caveolin localization in the 
rafts was not affected by the PDMP treatment, which is in line with 
previous observations (Naslavsky et al., 1999). 
To summarize, our study clearly showed that treatment of cells 
with MI3CD and PDMP resulted in compound-specific modulations 
of the lipid composition of the cells, and both led to a shift of 
P-gp from raft to nonraft fractions. Removal of cholesterol resulted 
in the release of P-gp and GSLs fiom the membranes of intact cells 
and from total membranes. These modulations of the lipid compo- 
sition resulted in loss of P-gp efflux activity in viable cells. 
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